中国病理生理杂志
中國病理生理雜誌
중국병리생리잡지
CHINESE JOURNAL OF PATHOPHYSIOLOGY
2006年
12期
2390-2396
,共7页
高大新%张海燕%李永军%王岩峰%黄涛%吕刚
高大新%張海燕%李永軍%王巖峰%黃濤%呂剛
고대신%장해연%리영군%왕암봉%황도%려강
骨肉瘤%寡核苷酸类,反义%顺铂%小鼠,裸
骨肉瘤%寡覈苷痠類,反義%順鉑%小鼠,裸
골육류%과핵감산류,반의%순박%소서,라
Osteosarcoma%Oligonucleotides,antisense%Cisplatin%Mice,nude
目的:探讨反义基因治疗与化疗联合应用提高骨肉瘤疗效的可行性及其机制.方法:通过构建荷骨肉瘤裸鼠模型,采用瘤内注射和腹腔给药方式,以survivin反义寡核苷酸(ASODN)配合顺铂(DDP)对瘤鼠进行联合干预治疗,并与各单药组进行比较,观测各组裸鼠肿瘤生长情况、评估瘤体病理形态,免疫组织化学法检测瘤组织survivin蛋白表达,DNA末端原位标记法(TUNEL法)检测肿瘤细胞凋亡水平.结果:与各单药组相比,联合治疗组在显著下调survivin蛋白表达同时,肿瘤细胞凋亡坏死更为明显,肿瘤生长受抑效果更强.结论:ASODN对DDP具有明显增效作用,可弥补DDP耐药缺陷,二者联合可望发挥协同抗瘤效应.
目的:探討反義基因治療與化療聯閤應用提高骨肉瘤療效的可行性及其機製.方法:通過構建荷骨肉瘤裸鼠模型,採用瘤內註射和腹腔給藥方式,以survivin反義寡覈苷痠(ASODN)配閤順鉑(DDP)對瘤鼠進行聯閤榦預治療,併與各單藥組進行比較,觀測各組裸鼠腫瘤生長情況、評估瘤體病理形態,免疫組織化學法檢測瘤組織survivin蛋白錶達,DNA末耑原位標記法(TUNEL法)檢測腫瘤細胞凋亡水平.結果:與各單藥組相比,聯閤治療組在顯著下調survivin蛋白錶達同時,腫瘤細胞凋亡壞死更為明顯,腫瘤生長受抑效果更彊.結論:ASODN對DDP具有明顯增效作用,可瀰補DDP耐藥缺陷,二者聯閤可望髮揮協同抗瘤效應.
목적:탐토반의기인치료여화료연합응용제고골육류료효적가행성급기궤제.방법:통과구건하골육류라서모형,채용류내주사화복강급약방식,이survivin반의과핵감산(ASODN)배합순박(DDP)대류서진행연합간예치료,병여각단약조진행비교,관측각조라서종류생장정황、평고류체병리형태,면역조직화학법검측류조직survivin단백표체,DNA말단원위표기법(TUNEL법)검측종류세포조망수평.결과:여각단약조상비,연합치료조재현저하조survivin단백표체동시,종류세포조망배사경위명현,종류생장수억효과경강.결론:ASODN대DDP구유명현증효작용,가미보DDP내약결함,이자연합가망발휘협동항류효응.
AIM: To investigate the feasibility and its mechanisms of improving therapeutic effect by antisense gene therapy combined with chemotherapy in osteosarcoma. METHODS: The human osteosarcoma implanted tumor model in the nude mice was established. By intratumoral injection and abdominal cavity administration, the tumor bearing mice were treated with survivin ASODN in combination with diamminedichloroplatinum (DDP) for a week. Comparison with each single - agent therapy and control group was performed in aspects such as tumor growth condition, pathological changes of tumor tissues; survivin protein expression in tumor tissues by immunohistochemistry, survivin mRNA expression levels by RT -PCR method and tumor apoptosis by Tdt -mediated dUTP nick end labeling (TUNEL). RESULTS: All nude mice survived the therapy. As compared with the control group, the antisense gene therapy group presented synchronous decrease in survivin mRNA and protein expression; all therapy group displayed tumor growth inhibition and cell apoptosis with different extent; while in contrast to single - agent therapy group, the combined therapy group showed stronger inhibition of tumor growth and abundant tumor cell apoptosis with the highest apoptotic rate. CONCLUSION: Synergistic effect was achieved by combination of DDP with ASODN that may overcome drug resistant of DDP and the combined strategy may shed new light on the cancer therapy.